Financial Information
This section of the Zynex Medical InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing.
Please note: All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes. Zynex Medical assumes no responsibility for the accuracy of this data and provides it for informational purposes only.
OTCIDZYXI
| Beta | 1.20 |
|---|---|
| Shares Outstanding | 30.4M |
| Average Volume (10 days) | 0 |
| Qtrly Dividend (Ann. Yield) | -- (--) |
Analyst Views
| Current Mean Recommendation | Hold |
|---|
| Strong Buy | 0 | |
|---|---|---|
| Buy | 0 | |
| Hold | 1 | |
| Underperform | 0 | |
| Sell | 0 |
Recent Insider Transactions
Michael Cress Director | (12,499) Dispose Mar 26, 2026 |
|---|---|
Michael Cress Director | (82,501) Dispose Mar 26, 2026 |
Barry D. Michaels Director | (80,001) Dispose Mar 26, 2026 |
Joshua R. Disbrow Director | (12,499) Dispose Mar 26, 2026 |
Joshua R. Disbrow Director | (89,501) Dispose Mar 26, 2026 |